This page shows you your search results in order of date. This is page number 19.
Order by Relevance | Date
Total 17126 results found since Jan 2013.
Review of Superficial Cryotherapy for the Treatment of Alopecia Areata
J Drugs Dermatol. 2023 Aug 1;22(8):802-809. doi: 10.36849/jdd.7431.ABSTRACTCryotherapy has recently been examined as a potential treatment for alopecia areata (AA). AA is classically managed with intralesional or systemic steroids but relapse rates among those with longstanding disease are high. This narrative review serves to describe the existing studies evaluating cryotherapy for the treatment of AA and examine studies comparing cryotherapy with intralesional steroid injection for the treatment of AA. A review of the literature from 1990 to 2022 was conducted looking for keywords such as “alopecia areata&r...
Source: Journal of Drugs in Dermatology - August 9, 2023 Category: Dermatology Authors: Michael Kaiser Najy Issa Marita Yaghi Joaquin J Jimenez Naiem T Issa Source Type: research
Off-Label Use of Baricitinib in Dermatology
J Drugs Dermatol. 2023 Aug 1;22(8):795-801. doi: 10.36849/jdd.7360.ABSTRACTThe current US Food and Drug Administration (FDA) indications for baricitinib include alopecia areata, rheumatoid arthritis, and COVID-19. However, increasing evidence indicates that baricitinib is effective in treating a variety of dermatological conditions. This review article comprehensively presents the available literature on this topic and will be of interest to practitioners in the field. These disorders may be broadly classified as connective tissue diseases, eczematous dermatoses, alopecias, vascular disorders, granulomatous diseases, neutr...
Source: Journal of Drugs in Dermatology - August 9, 2023 Category: Dermatology Authors: Asghar Shah Sara Yumeen Abrar Qureshi Elie Saliba Source Type: research
Review of Superficial Cryotherapy for the Treatment of Alopecia Areata
J Drugs Dermatol. 2023 Aug 1;22(8):802-809. doi: 10.36849/jdd.7431.ABSTRACTCryotherapy has recently been examined as a potential treatment for alopecia areata (AA). AA is classically managed with intralesional or systemic steroids but relapse rates among those with longstanding disease are high. This narrative review serves to describe the existing studies evaluating cryotherapy for the treatment of AA and examine studies comparing cryotherapy with intralesional steroid injection for the treatment of AA. A review of the literature from 1990 to 2022 was conducted looking for keywords such as “alopecia areata&r...
Source: Journal of Drugs in Dermatology - August 9, 2023 Category: Dermatology Authors: Michael Kaiser Najy Issa Marita Yaghi Joaquin J Jimenez Naiem T Issa Source Type: research
Off-Label Use of Baricitinib in Dermatology
J Drugs Dermatol. 2023 Aug 1;22(8):795-801. doi: 10.36849/jdd.7360.ABSTRACTThe current US Food and Drug Administration (FDA) indications for baricitinib include alopecia areata, rheumatoid arthritis, and COVID-19. However, increasing evidence indicates that baricitinib is effective in treating a variety of dermatological conditions. This review article comprehensively presents the available literature on this topic and will be of interest to practitioners in the field. These disorders may be broadly classified as connective tissue diseases, eczematous dermatoses, alopecias, vascular disorders, granulomatous diseases, neutr...
Source: Journal of Drugs in Dermatology - August 9, 2023 Category: Dermatology Authors: Asghar Shah Sara Yumeen Abrar Qureshi Elie Saliba Source Type: research
Review of Superficial Cryotherapy for the Treatment of Alopecia Areata
J Drugs Dermatol. 2023 Aug 1;22(8):802-809. doi: 10.36849/jdd.7431.ABSTRACTCryotherapy has recently been examined as a potential treatment for alopecia areata (AA). AA is classically managed with intralesional or systemic steroids but relapse rates among those with longstanding disease are high. This narrative review serves to describe the existing studies evaluating cryotherapy for the treatment of AA and examine studies comparing cryotherapy with intralesional steroid injection for the treatment of AA. A review of the literature from 1990 to 2022 was conducted looking for keywords such as “alopecia areata&r...
Source: Journal of Drugs in Dermatology - August 9, 2023 Category: Dermatology Authors: Michael Kaiser Najy Issa Marita Yaghi Joaquin J Jimenez Naiem T Issa Source Type: research
Off-Label Use of Baricitinib in Dermatology
J Drugs Dermatol. 2023 Aug 1;22(8):795-801. doi: 10.36849/jdd.7360.ABSTRACTThe current US Food and Drug Administration (FDA) indications for baricitinib include alopecia areata, rheumatoid arthritis, and COVID-19. However, increasing evidence indicates that baricitinib is effective in treating a variety of dermatological conditions. This review article comprehensively presents the available literature on this topic and will be of interest to practitioners in the field. These disorders may be broadly classified as connective tissue diseases, eczematous dermatoses, alopecias, vascular disorders, granulomatous diseases, neutr...
Source: Journal of Drugs in Dermatology - August 9, 2023 Category: Dermatology Authors: Asghar Shah Sara Yumeen Abrar Qureshi Elie Saliba Source Type: research
Review of Superficial Cryotherapy for the Treatment of Alopecia Areata
J Drugs Dermatol. 2023 Aug 1;22(8):802-809. doi: 10.36849/jdd.7431.ABSTRACTCryotherapy has recently been examined as a potential treatment for alopecia areata (AA). AA is classically managed with intralesional or systemic steroids but relapse rates among those with longstanding disease are high. This narrative review serves to describe the existing studies evaluating cryotherapy for the treatment of AA and examine studies comparing cryotherapy with intralesional steroid injection for the treatment of AA. A review of the literature from 1990 to 2022 was conducted looking for keywords such as “alopecia areata&r...
Source: Journal of Drugs in Dermatology - August 9, 2023 Category: Dermatology Authors: Michael Kaiser Najy Issa Marita Yaghi Joaquin J Jimenez Naiem T Issa Source Type: research
Off-Label Use of Baricitinib in Dermatology
J Drugs Dermatol. 2023 Aug 1;22(8):795-801. doi: 10.36849/jdd.7360.ABSTRACTThe current US Food and Drug Administration (FDA) indications for baricitinib include alopecia areata, rheumatoid arthritis, and COVID-19. However, increasing evidence indicates that baricitinib is effective in treating a variety of dermatological conditions. This review article comprehensively presents the available literature on this topic and will be of interest to practitioners in the field. These disorders may be broadly classified as connective tissue diseases, eczematous dermatoses, alopecias, vascular disorders, granulomatous diseases, neutr...
Source: Journal of Drugs in Dermatology - August 9, 2023 Category: Dermatology Authors: Asghar Shah Sara Yumeen Abrar Qureshi Elie Saliba Source Type: research
Review of Superficial Cryotherapy for the Treatment of Alopecia Areata
J Drugs Dermatol. 2023 Aug 1;22(8):802-809. doi: 10.36849/jdd.7431.ABSTRACTCryotherapy has recently been examined as a potential treatment for alopecia areata (AA). AA is classically managed with intralesional or systemic steroids but relapse rates among those with longstanding disease are high. This narrative review serves to describe the existing studies evaluating cryotherapy for the treatment of AA and examine studies comparing cryotherapy with intralesional steroid injection for the treatment of AA. A review of the literature from 1990 to 2022 was conducted looking for keywords such as “alopecia areata&r...
Source: Journal of Drugs in Dermatology - August 9, 2023 Category: Dermatology Authors: Michael Kaiser Najy Issa Marita Yaghi Joaquin J Jimenez Naiem T Issa Source Type: research
Off-Label Use of Baricitinib in Dermatology
J Drugs Dermatol. 2023 Aug 1;22(8):795-801. doi: 10.36849/jdd.7360.ABSTRACTThe current US Food and Drug Administration (FDA) indications for baricitinib include alopecia areata, rheumatoid arthritis, and COVID-19. However, increasing evidence indicates that baricitinib is effective in treating a variety of dermatological conditions. This review article comprehensively presents the available literature on this topic and will be of interest to practitioners in the field. These disorders may be broadly classified as connective tissue diseases, eczematous dermatoses, alopecias, vascular disorders, granulomatous diseases, neutr...
Source: Journal of Drugs in Dermatology - August 9, 2023 Category: Dermatology Authors: Asghar Shah Sara Yumeen Abrar Qureshi Elie Saliba Source Type: research
